Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program

被引:15
|
作者
Alfaro, Karla M. [1 ]
Gage, Julia C. [2 ]
Rosenbaum, Alan J. [3 ,4 ,5 ]
Ditzian, Lauren R. [1 ]
Maza, Mauricio [1 ]
Scarinci, Isabel C. [6 ]
Miranda, Esmeralda [7 ]
Villalta, Sofia [7 ]
Felix, Juan C. [8 ]
Castle, Philip E. [9 ]
Cremer, Miriam L. [10 ]
机构
[1] Basic Hlth Int, San Salvador, El Salvador
[2] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA
[3] Univ Pittsburgh, Dept Obstet & Gynecol, Sch Med, Pittsburgh, PA 15213 USA
[4] US Dept State, Fulbright US Student Program, Washington, DC 20005 USA
[5] Ohio State Univ, Wexner Med Ctr, Dept Obstet & Gynecol, Columbus, OH 43210 USA
[6] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35205 USA
[7] Minist Hlth El Salvador, San Salvador, El Salvador
[8] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA
[9] Global Canc Initiat, Chestertown, MD 21620 USA
[10] Cleveland Clin, OB GYN & Womens Hlth Inst, Cleveland, OH 44195 USA
来源
BMC PUBLIC HEALTH | 2015年 / 15卷
关键词
HPV; Community health promoters; Cervical cancer; Adherence; Screening; Underserved populations; Education; PARTICIPATION; PERCEPTIONS; PREVENTION; BARRIERS;
D O I
10.1186/s12889-015-2360-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Cervical cancer is the third most commonly occurring cancer among women and the fourth leading cause of cancer-related deaths in women worldwide, with more than 85 % of these cases occurring in developing countries. These global disparities reflect the differences in cervical cancer screening rates between high-income and medium-and low-income countries. At 19 %, El Salvador has the lowest reported screening coverage of all Latin American countries. The purpose of this study is to identify factors affecting public sector HPV DNA-based cervical cancer screening participation in El Salvador. Methods: This study was nested within a public sector screening program where health promoters used door-to-door outreach to recruit women aged 30-49 years to attend educational sessions about HPV screening. A subgroup of these participants was chosen randomly and questioned about demographic factors, healthcare utilization, previous cervical cancer screening, and HPV knowledge. Women then scheduled screening appointments at their public health clinics. Screening participants were adherent if they attended their scheduled appointment or rescheduled and were screened within 6 months. The association between non-adherence and demographic variables, medical history, history of cancer, sexual history, birth control methods, and screening barriers was assessed using Chi-square tests of significance and logistic regression. Results: All women (n = 409) enrolled in the study scheduled HPV screening appointments, and 88 % attended. Non-adherence was associated with a higher number of lifetime partners and being under-screened-defined as not having participated in cervical cancer screening within the previous 3 years (p = 0.03 and p = 0.04, respectively); 22.8 % of participants in this study were under-screened. Conclusions: Adherence to cervical cancer screening after educational sessions was higher than expected, in part due to interactions with the community-based health promoters as well as the educational session itself. More effective recruitment methods targeted toward under-screened women are required.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program
    Karla M. Alfaro
    Julia C. Gage
    Alan J. Rosenbaum
    Lauren R. Ditzian
    Mauricio Maza
    Isabel C. Scarinci
    Esmeralda Miranda
    Sofia Villalta
    Juan C. Felix
    Philip E. Castle
    Miriam L. Cremer
    BMC Public Health, 15
  • [2] Cervical cancer screening attendance related factors among women in Latvia
    Springe, Lauma
    Kivite-Urtane, A.
    Kursite, M.
    Curkste, A.
    Zodzika, J.
    Parna, K.
    Uuskula, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [3] The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
    Campos, Nicole G.
    Maza, Mauricio
    Alfaro, Karla
    Gage, Julia C.
    Castle, Philip E.
    Felix, Juan C.
    Masch, Rachel
    Cremer, Miriam
    Kim, Jane J.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (01) : 40 - 46
  • [4] Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania
    Linde, Ditte Sondergaard
    Rasch, Vibeke
    Mwaiselage, Julius D.
    Gammeltoft, Tine M.
    BMJ OPEN, 2019, 9 (02):
  • [5] Factors Affecting Cervical Screening Among Turkish Women
    Erbil, Nulufer
    Tezcan, Yasemin
    Gur, Elif Nur
    Yildirim, Merve
    Alis, Neslihan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2010, 11 (06) : 1641 - 1644
  • [6] BREAST AND CERVICAL CANCER SCREENING ATTENDANCE AMONG CZECH WOMEN
    Altova, Anna
    Kulhanova, Ivana
    Bruha, Lukas
    Lustigova, Michala
    CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 29 (02) : 90 - 95
  • [7] Barriers to the cervical cancer screening attendance among Czech women
    Altova, A.
    Lustigova, M.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2022, 87 (04): : 239 - 244
  • [8] Attendance to mass screening program among young women with cervical carcinoma in Finland
    Armfelt, Lotta
    Malila, Nea
    Carpen, Olli
    Grenman, Seija
    Rintala, Marjut
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 : 63 - 64
  • [9] Factors affecting breast and cervical cancer screening in women with disabilities
    Welner, SL
    JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 1999, 8 (05): : 715 - 715
  • [10] Cervical screening attendance and cervical cancer risk among women who have sex with women
    Saunders, Catherine L.
    Massou, Efthalia
    Waller, Jo
    Meads, Catherine
    Marlow, Laura A., V
    Usher-Smith, Juliet A.
    JOURNAL OF MEDICAL SCREENING, 2021, 28 (03) : 349 - 356